Comprehensive 1-year cost analysis of open antireflux surgery in Nordic countries
- 1 July 1998
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 85 (7) , 1002-1005
- https://doi.org/10.1046/j.1365-2168.1998.00834.x
Abstract
Background: Antireflux surgery is a highly effective treatment option in patients with severe gastro-oesophageal reflux disease. However, because of the increasing pressure of cost containment within health care, cost aspects must also be added to the decision-making process. Methods: The aim of this analysis was to assess the total cost of open antireflux surgery during the first year after operation in 178 patients with chronic reflux, who were recruited into a controlled, prospective clinical trial. The study was carried out in 17 hospitals in the Nordic countries. Results: The cost of the operation represented more than 90 per cent of the direct medical costs which amounted to approximately US $5700. For a patient in the work force the indirect cost, i.e. loss of production, represented 47 per cent of the total cost, which was about US $10 800. Conclusion: The total cost profile of open antireflux surgery has now been established prospectively and can form a basis for future comparisons.Keywords
This publication has 13 references indexed in Scilit:
- Choice of long-term strategy for the management of patients with severe esophagitis: A cost-utility analysisGastroenterology, 1997
- Long-term results of a prospective randomized comparison of total fundic wrap (Nissen-Rossetti) or semifundoplication (Toupet) for gastro-oesophageal refluxBritish Journal of Surgery, 1996
- Cost Effectiveness of Medical versus Surgical Treatment in Patients with Severe or Refractory Gastroesophageal Reflux Disease in The NetherlandsScandinavian Journal of Gastroenterology, 1996
- Long-Term Treatment with Omeprazole for Refractory Reflux Esophagitis: Efficacy and SafetyAnnals of Internal Medicine, 1994
- OmeprazolePharmacoEconomics, 1993
- Towards a new approach for estimating indirect costs of diseaseSocial Science & Medicine, 1992
- Estimating Costs in the Economic Evaluation of Medical TechnologiesInternational Journal of Technology Assessment in Health Care, 1990
- A Long-Term Randomized Prospective Trial of the Nissen Procedure Versus a Modified Toupet TechniqueAnnals of Surgery, 1989
- Omeprazole or Ranitidine in the Treatment of Reflux Esophagitis: Results of a Double-Blind, Randomized, Scandinavian Multicenter StudyScandinavian Journal of Gastroenterology, 1987
- Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesNew England Journal of Medicine, 1977